Mutations in ANK1 and MTR, which were heterogeneous in three patients each, as well as aberrations in PCLO, which were shared in six patients and recently identified as recurrently mutated in MM cell lines41, are additional candidates. Here, ANK1 is linked to Miyoshi myopathy.